ArticleProceedings of the National Academy of Sciences of the United States of America2024

Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria.

Douglas L Huseby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.